{"id":"NCT02325219","sponsor":"Janssen Pharmaceutical K.K.","briefTitle":"An Efficacy and Safety of CNTO 1959 (Guselkumab) in Participants With Moderate to Severe Plaque-type Psoriasis","officialTitle":"A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of CNTO 1959 (Guselkumab) in the Treatment of Subjects With Moderate to Severe Plaque-type Psoriasis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-12-19","primaryCompletion":"2016-03-02","completion":"2019-02-08","firstPosted":"2014-12-24","resultsPosted":"2020-05-14","lastUpdate":"2020-05-22"},"enrollment":192,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Psoriasis"],"interventions":[{"type":"DRUG","name":"CNTO 1959 50 mg","otherNames":["Guselkumab"]},{"type":"DRUG","name":"CTNO 1959 100 mg","otherNames":["Guselkumab"]},{"type":"DRUG","name":"Placebo 50 mg","otherNames":[]},{"type":"DRUG","name":"Placebo 100 mg","otherNames":[]}],"arms":[{"label":"Group 1","type":"EXPERIMENTAL"},{"label":"Group 2","type":"EXPERIMENTAL"},{"label":"Group 3","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to demonstrate the superiority of CNTO 1959 (guselkumab) to placebo in the treatment of participants with moderate to severe plaque-type psoriasis (A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches).","primaryOutcome":{"measure":"Percentage of Participants With an Investigator's Global Assessment (IGA) Score of Cleared (0) or Minimal (1) at Week 16","timeFrame":"Week 16","effectByArm":[{"arm":"Placebo (CP)","deltaMin":7.8,"sd":null},{"arm":"Guselkumab 50 mg (CP)","deltaMin":92.3,"sd":null},{"arm":"Guselkumab 100 mg (CP)","deltaMin":88.9,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"},{"comp":"OG000 vs OG002","p":"< 0.001"}]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":5},"locations":{"siteCount":27,"countries":["Japan"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":64},"commonTop":["Nasopharyngitis","Hypertension","Influenza","Dental Caries","Arthralgia"]}}